Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/3/2025 | $108.00 | Market Perform | BMO Capital Markets |
| 9/12/2024 | $109.00 | Equal Weight | Wells Fargo |
| 8/27/2024 | $99.00 | Underweight | Barclays |
| 4/11/2024 | $106.00 → $120.00 | Underperform → Mkt Perform | Keefe Bruyette |
| 4/8/2024 | $92.00 → $114.00 | Sell → Hold | TD Cowen |
| 1/8/2024 | $95.00 → $105.00 | Equal Weight → Underweight | Wells Fargo |
| 1/4/2024 | $88.00 | Underperform | TD Cowen |
| 10/31/2023 | $100.00 → $95.00 | Sell → Neutral | Citigroup |
BALTIMORE, March 20, 2026 (GLOBE NEWSWIRE) -- Longeviti Neuro Solutions, a neurotechnology company developing advanced implantable and AI-enabled solutions for neurological health including the ClearFit AI™, the first Acoustic Brain Interface (ABI)™, today announced the appointment of Robert W. Sharps, Chief Executive Officer and President of T. Rowe Price Group, Inc. (NASDAQ:TROW), to its Board of Directors. Sharps brings three decades of leadership experience in global asset management, capital markets, corporate governance, and strategic growth. As CEO and the Chairman of the Board of T. Rowe Price, he oversees one of the world's leading investment firms, managing more than $1.5 trilli
Multi-strategy credit interval fund offers public and private market credit exposure with a flexible approach that can adapt to changing market conditionsOFLEX marks the continued partnership of T. Rowe Price and Oak Hill Advisors as they expand their alternative investment capabilities globallyNEW YORK, March 19, 2026 /PRNewswire/ -- T. Rowe Price and Oak Hill Advisors ('OHA') today announced the launch of the T. Rowe Price OHA Flexible Credit Income Fund ('OFLEX' or 'the Fund'), a multi-strategy credit interval fund that can invest across the credit spectrum in both private and public markets.
Firm expands retirement leadership team, reinforcing its commitment to advancing its global retirement capabilitiesBALTIMORE, March 18, 2026 /PRNewswire/ -- T. Rowe Price, a global asset management firm and a leader in retirement, today announced that it is expanding the leadership team responsible for delivering world class global retirement capabilities. The expanded team now includes Jessica Sclafani, CAIA©, who will become head of the Retirement Strategist team; Richard Parkin, who recently joined T. Rowe Price as the head of UK Retirement; and Scott Keller, head of Americas, APAC, and EMEA Distribution, who will take on an expanded remit to include oversight of retirement strategy execu
BMO Capital Markets initiated coverage of T. Rowe Price with a rating of Market Perform and set a new price target of $108.00
Wells Fargo initiated coverage of T. Rowe Price with a rating of Equal Weight and set a new price target of $109.00
Barclays initiated coverage of T. Rowe Price with a rating of Underweight and set a new price target of $99.00
DEFA14A - PRICE T ROWE GROUP INC (0001113169) (Filer)
DEF 14A - PRICE T ROWE GROUP INC (0001113169) (Filer)
10-K - PRICE T ROWE GROUP INC (0001113169) (Filer)
4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)
4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)
4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)
SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)
SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)
SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)
BALTIMORE, Feb. 4, 2026 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced its financial results for the fourth quarter and full year 2025. The earnings release can be found on the firm's website at troweprice.com/newsroom. Chair, CEO, and President Rob Sharps and Chief Financial Officer Jen Dardis will provide an update on business performance, review financial results, and answer questions on a webcast today from 8:00 - 8:45 AM (Eastern Time). To access the webcast or to obtain dial-in instructions to ask a question, please visit investors.troweprice.com.
BALTIMORE, Oct. 31, 2025 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced its financial results for the third quarter of 2025. The earnings release can be found on the firm's website at troweprice.com/newsroom. Chair, Chief Executive Officer, and President Rob Sharps and Chief Financial Officer Jen Dardis will provide an update on business performance, review financial results, and answer questions on a webcast today from 8:00 - 8:45 AM ET. To access the webcast or to obtain dial-in instructions to ask a question, please visit investors.troweprice.com. Sup
BALTIMORE, Oct. 28, 2025 /PRNewswire/ -- T. Rowe Price Group (NASDAQ-GS: TROW), a global asset management firm and a leader in retirement, announced today that its Board of Directors has declared a quarterly dividend of $1.27 per share payable on December 30, 2025, to stockholders of record as of the close of business on December 15, 2025. ABOUT T. ROWE PRICE T. Rowe Price (NASDAQ-GS: TROW) is a leading global asset management firm entrusted with managing $1.77 trillion in client assets as of September 30, 2025, about two-thirds of which are retirement-related. Renowned for ov
BALTIMORE, March 20, 2026 (GLOBE NEWSWIRE) -- Longeviti Neuro Solutions, a neurotechnology company developing advanced implantable and AI-enabled solutions for neurological health including the ClearFit AI™, the first Acoustic Brain Interface (ABI)™, today announced the appointment of Robert W. Sharps, Chief Executive Officer and President of T. Rowe Price Group, Inc. (NASDAQ:TROW), to its Board of Directors. Sharps brings three decades of leadership experience in global asset management, capital markets, corporate governance, and strategic growth. As CEO and the Chairman of the Board of T. Rowe Price, he oversees one of the world's leading investment firms, managing more than $1.5 trilli
Steven Krichbaum named successor and new head of TRPIM in 2027 BALTIMORE, Jan. 22, 2026 /PRNewswire/ -- T. Rowe Price announced today a planned leadership transition within its T. Rowe Price Investment Management division (TRPIM), as Steph Jackson, who currently serves as head of TRPIM and is a member of the Management Committee, will be retiring at the end of 2026. Jackson's tenure at T. Rowe Price has been marked by impactful leadership and a steadfast commitment to clients, associates, and community. Since joining T. Rowe Price in 2007, Jackson has held influential roles,
Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as